β-cyclodextrin and curcumin, a potent cocktail for disaggregating and/or inhibiting amyloids: a case study with α-synuclein.
Saurabh Gautam, Sandip Karmakar, Abhik Bose, Pramit K Chowdhury
Index: Biochemistry 53(25) , 4081-3, (2014)
Full Text: HTML
Abstract
Aggregation of α-synuclein has been implicated in Parkinson's disease (PD). While many compounds are known to inhibit α-synuclein aggregation, dissolution of aggregates into their constituent monomers cannot be readily achieved. In this study, using a range of techniques, we have shown that an optimized cocktail of curcumin and β-cyclodextrin, at appreciably low concentrations, not only inhibited aggregation but also broke up the preformed aggregates almost completely. We propose that these compounds exhibit synergy in their action and thus provide us with the exciting prospect of working toward the development of a suitable drug candidate for prevention and treatment of PD.
Related Compounds
Related Articles:
2014-11-01
[J. Pharm. Sci. 103(11) , 3764-71, (2014)]
Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site.
2015-03-14
[Org. Biomol. Chem. 13(10) , 3040-7, (2015)]
An antifungal mechanism of curcumin lies in membrane-targeted action within Candida albicans.
2014-11-01
[IUBMB Life 66(11) , 780-5, (2015)]
2014-06-01
[Invest. Ophthalmol. Vis. Sci. 55(6) , 3423-31, (2014)]
2015-03-01
[Int. J. Biochem. Cell Biol. 60 , 119-29, (2015)]